Global Ciclesonide Market Growth (Status and Outlook) 2025-2031

December 2025 | 79 pages | ID: GED13B01EB4EN
LP Information

Abstracts

According to this study, the global Ciclesonide market size will reach US$ million by 2031.

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada.

United States market for Ciclesonide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Ciclesonide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Ciclesonide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Ciclesonide players cover Covis Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Ciclesonide Industry Forecast” looks at past sales and reviews total world Ciclesonide sales in 2024, providing a comprehensive analysis by region and market sector of projected Ciclesonide sales for 2025 through 2031. With Ciclesonide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ciclesonide industry.

This Insight Report provides a comprehensive analysis of the global Ciclesonide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ciclesonide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ciclesonide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ciclesonide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ciclesonide.

This report presents a comprehensive overview, market shares, and growth opportunities of Ciclesonide market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Inhalation Aerosol 37 mcg/actuation
• Inhalation Aerosol 80 mcg/actuation
• Inhalation Aerosol 120 mcg/actuation
• Inhalation Aerosol 160 mcg/actuation

Segmentation by Application:

• Adults
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Covis Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ciclesonide Market Size (2020-2031)
  2.1.2 Ciclesonide Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Ciclesonide by Country/Region (2020, 2024 & 2031)
2.2 Ciclesonide Segment by Type
  2.2.1 Inhalation Aerosol 37 mcg/actuation
  2.2.2 Inhalation Aerosol 80 mcg/actuation
  2.2.3 Inhalation Aerosol 120 mcg/actuation
  2.2.4 Inhalation Aerosol 160 mcg/actuation
2.3 Ciclesonide Market Size by Type
  2.3.1 Ciclesonide Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Ciclesonide Market Size Market Share by Type (2020-2025)
2.4 Ciclesonide Segment by Application
  2.4.1 Adults
  2.4.2 Children
2.5 Ciclesonide Market Size by Application
  2.5.1 Ciclesonide Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Ciclesonide Market Size Market Share by Application (2020-2025)

3 CICLESONIDE MARKET SIZE BY PLAYER

3.1 Ciclesonide Market Size Market Share by Player
  3.1.1 Global Ciclesonide Revenue by Player (2020-2025)
  3.1.2 Global Ciclesonide Revenue Market Share by Player (2020-2025)
3.2 Global Ciclesonide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CICLESONIDE BY REGION

4.1 Ciclesonide Market Size by Region (2020-2025)
4.2 Global Ciclesonide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ciclesonide Market Size Growth (2020-2025)
4.4 APAC Ciclesonide Market Size Growth (2020-2025)
4.5 Europe Ciclesonide Market Size Growth (2020-2025)
4.6 Middle East & Africa Ciclesonide Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Ciclesonide Market Size by Country (2020-2025)
5.2 Americas Ciclesonide Market Size by Type (2020-2025)
5.3 Americas Ciclesonide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ciclesonide Market Size by Region (2020-2025)
6.2 APAC Ciclesonide Market Size by Type (2020-2025)
6.3 APAC Ciclesonide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Ciclesonide Market Size by Country (2020-2025)
7.2 Europe Ciclesonide Market Size by Type (2020-2025)
7.3 Europe Ciclesonide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ciclesonide by Region (2020-2025)
8.2 Middle East & Africa Ciclesonide Market Size by Type (2020-2025)
8.3 Middle East & Africa Ciclesonide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CICLESONIDE MARKET FORECAST

10.1 Global Ciclesonide Forecast by Region (2026-2031)
  10.1.1 Global Ciclesonide Forecast by Region (2026-2031)
  10.1.2 Americas Ciclesonide Forecast
  10.1.3 APAC Ciclesonide Forecast
  10.1.4 Europe Ciclesonide Forecast
  10.1.5 Middle East & Africa Ciclesonide Forecast
10.2 Americas Ciclesonide Forecast by Country (2026-2031)
  10.2.1 United States Market Ciclesonide Forecast
  10.2.2 Canada Market Ciclesonide Forecast
  10.2.3 Mexico Market Ciclesonide Forecast
  10.2.4 Brazil Market Ciclesonide Forecast
10.3 APAC Ciclesonide Forecast by Region (2026-2031)
  10.3.1 China Ciclesonide Market Forecast
  10.3.2 Japan Market Ciclesonide Forecast
  10.3.3 Korea Market Ciclesonide Forecast
  10.3.4 Southeast Asia Market Ciclesonide Forecast
  10.3.5 India Market Ciclesonide Forecast
  10.3.6 Australia Market Ciclesonide Forecast
10.4 Europe Ciclesonide Forecast by Country (2026-2031)
  10.4.1 Germany Market Ciclesonide Forecast
  10.4.2 France Market Ciclesonide Forecast
  10.4.3 UK Market Ciclesonide Forecast
  10.4.4 Italy Market Ciclesonide Forecast
  10.4.5 Russia Market Ciclesonide Forecast
10.5 Middle East & Africa Ciclesonide Forecast by Region (2026-2031)
  10.5.1 Egypt Market Ciclesonide Forecast
  10.5.2 South Africa Market Ciclesonide Forecast
  10.5.3 Israel Market Ciclesonide Forecast
  10.5.4 Turkey Market Ciclesonide Forecast
10.6 Global Ciclesonide Forecast by Type (2026-2031)
10.7 Global Ciclesonide Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Ciclesonide Forecast

11 KEY PLAYERS ANALYSIS

11.1 Covis Pharma
  11.1.1 Covis Pharma Company Information
  11.1.2 Covis Pharma Ciclesonide Product Offered
  11.1.3 Covis Pharma Ciclesonide Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Covis Pharma Main Business Overview
  11.1.5 Covis Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ciclesonide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Ciclesonide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inhalation Aerosol 37 mcg/actuation
Table 4. Major Players of Inhalation Aerosol 80 mcg/actuation
Table 5. Major Players of Inhalation Aerosol 120 mcg/actuation
Table 6. Major Players of Inhalation Aerosol 160 mcg/actuation
Table 7. Ciclesonide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Ciclesonide Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Ciclesonide Market Size Market Share by Type (2020-2025)
Table 10. Ciclesonide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Ciclesonide Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Ciclesonide Market Size Market Share by Application (2020-2025)
Table 13. Global Ciclesonide Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Ciclesonide Revenue Market Share by Player (2020-2025)
Table 15. Ciclesonide Key Players Head office and Products Offered
Table 16. Ciclesonide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Ciclesonide Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Ciclesonide Market Size Market Share by Region (2020-2025)
Table 21. Global Ciclesonide Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Ciclesonide Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Ciclesonide Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Ciclesonide Market Size Market Share by Country (2020-2025)
Table 25. Americas Ciclesonide Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Ciclesonide Market Size Market Share by Type (2020-2025)
Table 27. Americas Ciclesonide Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Ciclesonide Market Size Market Share by Application (2020-2025)
Table 29. APAC Ciclesonide Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Ciclesonide Market Size Market Share by Region (2020-2025)
Table 31. APAC Ciclesonide Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Ciclesonide Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Ciclesonide Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Ciclesonide Market Size Market Share by Country (2020-2025)
Table 35. Europe Ciclesonide Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Ciclesonide Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Ciclesonide Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Ciclesonide Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Ciclesonide Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Ciclesonide
Table 41. Key Market Challenges & Risks of Ciclesonide
Table 42. Key Industry Trends of Ciclesonide
Table 43. Global Ciclesonide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Ciclesonide Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Ciclesonide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Ciclesonide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Covis Pharma Details, Company Type, Ciclesonide Area Served and Its Competitors
Table 48. Covis Pharma Ciclesonide Product Offered
Table 49. Covis Pharma Ciclesonide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Covis Pharma Main Business
Table 51. Covis Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Ciclesonide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ciclesonide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Ciclesonide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Ciclesonide Sales Market Share by Country/Region (2024)
Figure 8. Ciclesonide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Ciclesonide Market Size Market Share by Type in 2024
Figure 10. Ciclesonide in Adults
Figure 11. Global Ciclesonide Market: Adults (2020-2025) & ($ millions)
Figure 12. Ciclesonide in Children
Figure 13. Global Ciclesonide Market: Children (2020-2025) & ($ millions)
Figure 14. Global Ciclesonide Market Size Market Share by Application in 2024
Figure 15. Global Ciclesonide Revenue Market Share by Player in 2024
Figure 16. Global Ciclesonide Market Size Market Share by Region (2020-2025)
Figure 17. Americas Ciclesonide Market Size 2020-2025 ($ millions)
Figure 18. APAC Ciclesonide Market Size 2020-2025 ($ millions)
Figure 19. Europe Ciclesonide Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Ciclesonide Market Size 2020-2025 ($ millions)
Figure 21. Americas Ciclesonide Value Market Share by Country in 2024
Figure 22. United States Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Ciclesonide Market Size Market Share by Region in 2024
Figure 27. APAC Ciclesonide Market Size Market Share by Type (2020-2025)
Figure 28. APAC Ciclesonide Market Size Market Share by Application (2020-2025)
Figure 29. China Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 33. India Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Ciclesonide Market Size Market Share by Country in 2024
Figure 36. Europe Ciclesonide Market Size Market Share by Type (2020-2025)
Figure 37. Europe Ciclesonide Market Size Market Share by Application (2020-2025)
Figure 38. Germany Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 39. France Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Ciclesonide Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Ciclesonide Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Ciclesonide Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Ciclesonide Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Ciclesonide Market Size 2026-2031 ($ millions)
Figure 52. APAC Ciclesonide Market Size 2026-2031 ($ millions)
Figure 53. Europe Ciclesonide Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Ciclesonide Market Size 2026-2031 ($ millions)
Figure 55. United States Ciclesonide Market Size 2026-2031 ($ millions)
Figure 56. Canada Ciclesonide Market Size 2026-2031 ($ millions)
Figure 57. Mexico Ciclesonide Market Size 2026-2031 ($ millions)
Figure 58. Brazil Ciclesonide Market Size 2026-2031 ($ millions)
Figure 59. China Ciclesonide Market Size 2026-2031 ($ millions)
Figure 60. Japan Ciclesonide Market Size 2026-2031 ($ millions)
Figure 61. Korea Ciclesonide Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Ciclesonide Market Size 2026-2031 ($ millions)
Figure 63. India Ciclesonide Market Size 2026-2031 ($ millions)
Figure 64. Australia Ciclesonide Market Size 2026-2031 ($ millions)
Figure 65. Germany Ciclesonide Market Size 2026-2031 ($ millions)
Figure 66. France Ciclesonide Market Size 2026-2031 ($ millions)
Figure 67. UK Ciclesonide Market Size 2026-2031 ($ millions)
Figure 68. Italy Ciclesonide Market Size 2026-2031 ($ millions)
Figure 69. Russia Ciclesonide Market Size 2026-2031 ($ millions)
Figure 70. Egypt Ciclesonide Market Size 2026-2031 ($ millions)
Figure 71. South Africa Ciclesonide Market Size 2026-2031 ($ millions)
Figure 72. Israel Ciclesonide Market Size 2026-2031 ($ millions)
Figure 73. Turkey Ciclesonide Market Size 2026-2031 ($ millions)
Figure 74. Global Ciclesonide Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Ciclesonide Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Ciclesonide Market Size 2026-2031 ($ millions)